XRTX · XORTX Therapeutics Inc.

NasdaqHealthcareBiotechnology

Xortx Therapeutics Inc Is A Clinical-Stage Pharmaceutical Company Focused On Developing Therapies To Treat Gout And Progressive Kidney Disease Modulated By Aberrant Purine And Uric Acid Metabolism In Orphan Disease Indications Such As Allopurinol-Intolerant Gout And Autosomal Dominant Polycystic Kidney Disease, As Well As More Prevalent Type 2 Diabetic Nephropathy And Fatty Liver Disease. Its Focus Is On Developing Products To Slow And/Or Reverse The Progression Of These Diseases. The Company Operates In One Reportable Operating Segment: The Development And Commercialization Of Therapies To Treat Hyperuricemia-Related Diseases.

HealthcareNasdaqCAVery Low Float

FLOAT

1.7M

FREE FLOAT %

96%

SHARES O/S

1.8M

MARKET CAP

$1.7M

EXCHANGE

Nasdaq

COUNTRY

XRTX Catalyst History

No catalysts recorded for XRTX yet

Day Trader Sniper hasn't classified a publishable catalyst for XRTX yet. New events appear here as they're scored.

Be early on the next XRTX spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

XRTX · XORTX Therapeutics Inc.

XRTX Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.